文献速递技术与安全PET

人工智能在核医学中的应用

Artificial intelligence in nuclear medicine.
PubMed 文献 · Br J Radiol · 2026-01-01

本文综述了人工智能在核医学中的发展现状,指出硬件进步与深度学习、卷积神经网络推动了图像采集加速、图像质量提升、图像生成、图像解读辅助及治疗计划等应用,但核医学领域仅极少数人工智能成果达到商业成熟,且医疗人工智能应用越过原型阶段的比例据报道低至2%。

要点

  • 人工智能可用于加速采集、提升图像质量、辅助解读与治疗计划。
  • 核医学中极少数人工智能成果达到商业成熟。
  • 医疗人工智能应用越过原型阶段的比例据报道低至2%。

核心结论

  • 人工智能在核医学的诊断和治疗方面具有广阔前景,但多数能力尚未被充分利用,核医学领域极少数人工智能成果达到商业成熟。

研究设计与样本

  • 本文为综述,围绕核医学影像流程(图像采集与重建、后处理与图像准备、图像分析、临床解读决策支持)选述部分领域,并讨论从开发到临床实施的挑战与机遇。

临床应用与阅片要点

  • 人工智能可用于加速图像采集、提升图像质量、实现先进图像生成、辅助图像解读和辅助治疗计划。
  • 人工智能可用于预测最佳治疗策略、评估风险、优化患者流程与结局,甚至提升生产力,但这些能力尚未被充分利用。
  • 利用人工智能提供自动化、标准化的流程,可帮助将先进影像从主要大学中心推广至较小的地方诊所,从而使更广泛的患者受益。

局限性

  • 医疗人工智能应用越过原型阶段的比例据报道低至2%。
  • 核医学领域极少数人工智能成果达到商业成熟。
  • 人工智能在预测最佳治疗策略、评估风险、优化患者流程与结局及提升生产力等方面的能力尚未被充分利用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Artificial intelligence (AI) holds great promise for advancing diagnostics and treatment in nuclear medicine. The rapid growth of AI over the past decade has been largely driven by advances in hardware components such as graphics processing units (GPUs) and the introduction of deep learning (DL) and convolutional neural networks (CNN). The integration of AI and medical imaging has the potential to revolutionize nuclear medicine by, for example, accelerating image acquisition, enhancing image quality, enabling advanced image generation, assisting image interpretation, and aiding treatment planning. Clinical applications have been demonstrated for most medical specialties, including oncology, neurology, and radionuclide therapy. The utilization of AI to provide automated, standardized procedures can help bring advanced imaging from major university centres to smaller local clinics, thus benefiting a broader range of patients. Additionally, AI has vast potential for predicting optimal treatment strategies, assessing risk, optimizing patient flow and outcomes, and even improving productivity, but these capabilities have yet to be fully utilized. The fraction of clinical AI applications in general healthcare reaching beyond the prototyping phase is reported to be as low as 2%. Indeed, in nuclear medicine, very few AI developments have reached commercial maturity. Currently, most AI applications in nuclear medicine follow the imaging flow from image acquisition and reconstruction, post-processing and image preparation, image analysis, and decision support for clinical interpretation. Below, we will briefly review selected areas and comment on challenges and opportunities for AI in nuclear medicine, with a special focus on the transition from development to clinical implementation.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Andersen FL, Hansen AE. Artificial intelligence in nuclear medicine. Br J Radiol. 2026. PMID: 41564330. doi:10.1093/bjr/tqag012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。